Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:EQRR NASDAQ:GNOM NASDAQ:HRTS NASDAQ:THMZ On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEQRRProShares Equities For Rising Rates ETF$78.96$72.74$57.43▼$79.14$46.59M0.9110,849 shs20,462 shsGNOMGlobal X Genomics & Biotechnology ETF$46.54$44.93$30.32▼$51.42$52.13M1.198,213 shs3,046 shsHRTSTema Heart & Health ETF$34.36$33.66$26.78▼$36.65$51.20M0.76,253 shs1,291 shsTHMZLazard Equity Megatrends ETF$33.26$31.39$28.18▼$36.13$52.55M1.535,908 shs408 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEQRRProShares Equities For Rising Rates ETF0.00%+2.51%+6.14%+17.17%+37.49%GNOMGlobal X Genomics & Biotechnology ETF0.00%+5.03%+1.24%-0.62%+51.10%HRTSTema Heart & Health ETF0.00%+3.06%+2.91%-4.50%+26.18%THMZLazard Equity Megatrends ETF0.00%+1.37%+2.40%+5.79%+14.47%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEQRRProShares Equities For Rising Rates ETF$78.96$72.74$57.43▼$79.14$46.59M0.9110,849 shs20,462 shsGNOMGlobal X Genomics & Biotechnology ETF$46.54$44.93$30.32▼$51.42$52.13M1.198,213 shs3,046 shsHRTSTema Heart & Health ETF$34.36$33.66$26.78▼$36.65$51.20M0.76,253 shs1,291 shsTHMZLazard Equity Megatrends ETF$33.26$31.39$28.18▼$36.13$52.55M1.535,908 shs408 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEQRRProShares Equities For Rising Rates ETF0.00%+2.51%+6.14%+17.17%+37.49%GNOMGlobal X Genomics & Biotechnology ETF0.00%+5.03%+1.24%-0.62%+51.10%HRTSTema Heart & Health ETF0.00%+3.06%+2.91%-4.50%+26.18%THMZLazard Equity Megatrends ETF0.00%+1.37%+2.40%+5.79%+14.47%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEQRRProShares Equities For Rising Rates ETF 2.71Moderate Buy$78.96N/AGNOMGlobal X Genomics & Biotechnology ETF 2.62Moderate Buy$46.54N/AHRTSTema Heart & Health ETF 2.79Moderate Buy$34.36N/ATHMZLazard Equity Megatrends ETF 2.86Moderate Buy$33.26N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEQRRProShares Equities For Rising Rates ETFN/AN/AN/AN/AN/AN/AGNOMGlobal X Genomics & Biotechnology ETFN/AN/AN/AN/AN/AN/AHRTSTema Heart & Health ETFN/AN/AN/AN/AN/AN/ATHMZLazard Equity Megatrends ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEQRRProShares Equities For Rising Rates ETFN/AN/A16.51N/AN/AN/AN/AN/AN/AGNOMGlobal X Genomics & Biotechnology ETFN/A-$2.34N/AN/AN/AN/AN/AN/AN/AHRTSTema Heart & Health ETFN/AN/A22.06N/AN/AN/AN/AN/AN/ATHMZLazard Equity Megatrends ETFN/AN/A31.61N/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthEQRRProShares Equities For Rising Rates ETF$0.981.24%N/AN/AN/AGNOMGlobal X Genomics & Biotechnology ETF$0.621.33%N/AN/A N/AHRTSTema Heart & Health ETF$0.461.34%N/AN/AN/ATHMZLazard Equity Megatrends ETF$0.130.39%N/AN/AN/ALatest THMZ, GNOM, HRTS, and EQRR DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/24/2026EQRRProShares Equities For Rising Rates ETFQuarterly$0.23341.34%3/25/20263/25/20263/31/20263/19/2026THMZLazard Equity Megatrends ETFQuarterly$0.03810.52%3/20/20263/20/20263/23/2026(Data available from 1/1/2013 forward)Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEQRRProShares Equities For Rising Rates ETFN/AGNOMGlobal X Genomics & Biotechnology ETF56.95%HRTSTema Heart & Health ETFN/ATHMZLazard Equity Megatrends ETFN/AInsider OwnershipCompanyInsider OwnershipEQRRProShares Equities For Rising Rates ETFN/AGNOMGlobal X Genomics & Biotechnology ETF5.89%HRTSTema Heart & Health ETFN/ATHMZLazard Equity Megatrends ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableEQRRProShares Equities For Rising Rates ETFN/A590,000N/ANot OptionableGNOMGlobal X Genomics & Biotechnology ETFN/A1.12 millionN/AOptionableHRTSTema Heart & Health ETFN/A1.49 millionN/AN/ATHMZLazard Equity Megatrends ETFN/A1.58 millionN/AN/ATHMZ, GNOM, HRTS, and EQRR HeadlinesRecent News About These CompaniesLazard Converts Mutual Fund to International Equity ETFMay 12, 2025 | etftrends.comENew MarketBeat Followers Over TimeMedia Sentiment Over TimeTHMZ, GNOM, HRTS, and EQRR Company DescriptionsProShares Equities For Rising Rates ETF NASDAQ:EQRR$78.96 0.00 (0.00%) As of 05/22/2026 04:00 PM EasternThe ProShares Equities for Rising Rates ETF (EQRR) is an exchange-traded fund that mostly invests in large cap equity. The fund tracks an index of 50 US-listed large-cap stocks that are anticipated to perform favorably during periods of rising interest rates. EQRR was launched on Jul 24, 2017 and is managed by ProShares.Global X Genomics & Biotechnology ETF NASDAQ:GNOM$46.54 0.00 (0.00%) As of 05/22/2026 03:59 PM EasternComplete Genomics, Inc. is a life sciences company that has developed and commercialized a deoxyribonucleic acid (DNA) sequencing platform. Its complete genomics analysis platform (CGA) Platform, combines its human genome sequencing technology with its advanced informatics and data management software and its end-to-end, outsourced service model to provide its customers with data that is ready to be used for genome-based research. Its genome sequencing center combines a high-throughput sample preparation facility, a collection of its high-throughput sequencing instruments and a large- scale data center. Its customers include some of the global academic and government research centers and biopharmaceutical companies. Effective March 18, 2013, BGI-Shenzhen announced that through its wholly-owned subsidiary, Beta Acquisition Corporation, it has completed the acquisition of the Company.Tema Heart & Health ETF NASDAQ:HRTS$34.36 0.00 (0.00%) As of 05/22/2026 03:14 PM EasternThe Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. HRTS was launched on Nov 20, 2023 and is issued by Tema.Lazard Equity Megatrends ETF NASDAQ:THMZ$33.26 0.00 (0.00%) As of 05/22/2026 10:21 AM EasternThe Lazard Equity Megatrends ETF (THMZ) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, seeking long-term capital appreciation through investments in global companies of any market capitalization. The funds selection process aims to identify global megatrends and themes that are likely to shape the future. THMZ was launched on Apr 4, 2025 and is issued by Lazard. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/18 - 05/22 Ross Stores Earnings Beat Sends Stock To New Highs Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus? Workday Validates AI Flywheel: Stock Price Recovery Begins Apparel Earnings Winners and Losers: Ralph Lauren Takes Off SpaceX IPO: Opportunity? Or the Ultimate Hype Trade? The Careful Consumer: What Q1 Earnings Reveal—And Where Cracks May Appear Overextended, e.l.f. Beauty Is Primed to Rebound in Back Half Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
